Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28074744 | 0.98 | TSHR (0.57) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL80819 | 0.95 | TSHR (0.62) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL6151225 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL16286524 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL23174784 | 0.93 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL108693 | 0.89 | TSHR (0.52) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL28044492 | 0.88 | TSHR (0.50) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL6440674 | 0.85 | TSHR (0.50) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL7525910 | 0.84 | TSHR (0.57) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL7718673 | 0.83 | TSHR (0.42) | TSHRALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117304755-B | Powdery interfacial agent prepared from tertiary vinegar redispersible emulsion powder and preparation method thereof | 江苏福吉利亚建材有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4719751-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | claimed |
| WO-2025084741-A1 | POLYOLEFIN GRAFT COPOLYMER PRODUCED USING INITIATOR CONTAINING AZIDOFORMATE GROUP AND PRODUCTION METHOD THEREFOR | 세종대학교산학협력단 | 2025-04-24 | — | — | WO | claimed |
| CN-119350985-A | Acrylic ester modified polyurethane hot melt adhesive and preparation method and application thereof | 韦尔通科技股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| US-20240399627-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2024-12-05 | — | — | US | claimed |
| WO-2024246819-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2024-12-05 | — | — | WO | claimed |
| CN-115772379-B | UV delayed-curing double-component polyurethane adhesive and preparation method thereof | 韦尔通科技股份有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-117304755-A | Powdery interfacial agent prepared from tertiary vinegar redispersible emulsion powder and preparation method thereof | 江苏福吉利亚建材有限公司 | 2023-12-29 | — | — | CN | claimed |
| US-11834429-B2 | Monoethylenically unsaturated monomers and uses thereof | BOSTIK SA (FR) | 2023-12-05 | — | — | US | claimed |
| US-20210179576-A1 | MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF | UNIVERSITE DE RENNES (FR) | 2021-06-17 | — | — | US | claimed |
| EP-1149075-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-10-31 | — | — | EP | claimed |
| US-6291620-B1 | Polymer synthesis | E. I. DU PONT DE NEMOURS AND COMPANY | 2001-09-18 | — | — | US | claimed |
| EP-0791016-B1 | POLYMER SYNTHESIS | DU PONT (US) | 2000-07-12 | — | — | EP | claimed |
| WO-1999005099-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-02-04 | — | — | WO | claimed |
| EP-0772636-A4 | RADIATION- AND/OR MOISTURE-CURABLE SILICONE COMPOSITIONS | LOCTITE CORP (US) | 1997-09-24 | — | — | EP | claimed |
| EP-0791016-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-08-27 | — | — | EP | claimed |
| EP-0772636-A1 | RADIATION- AND/OR MOISTURE-CURABLE SILICONE COMPOSITIONS | LOCTITE CORPORATION (US) | 1997-05-14 | — | — | EP | claimed |
| WO-1996015157-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-05-23 | — | — | WO | claimed |
| US-5516812-A | UV-moisture dual cure silicone conformal coating compositions with improved surface tack | LOCTITE CORPORATION (US) | 1996-05-14 | — | — | US | claimed |
| WO-1996002579-A1 | RADIATION- AND/OR MOISTURE-CURABLE SILICONE COMPOSITIONS | LOCTITE CORPORATION (US) | 1996-02-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11834429-B2 | Monoethylenically unsaturated monomers and uses thereof | MEP1A, MEP1B, ALOX5 | TSHR 4885/4885ALDH1A1 581/4885CYP3A4 1457/4885 |
| US-20210179576-A1 | MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF | MEP1A, MEP1B, ALOX5 | TSHR 4885/4885ALDH1A1 581/4885CYP3A4 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.